Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study

BACKGROUND: Respiratory syncytial virus (RSV) represents a significant public health burden and the leading cause of lower respiratory tract infections globally, and it is the major cause of hospitalization during the winter. We aimed to evaluate the effectiveness of palivizumab prophylaxis to reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhalik, M., El-Atawi, K., Dash, S. K., Faquih, A., Satyan, A. D., Gourshettiwar, N., Khan, A., Varughese, S., Ramesh, A., Khamis, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913160/
https://www.ncbi.nlm.nih.gov/pubmed/31871513
http://dx.doi.org/10.1155/2019/2986286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913160/
https://www.ncbi.nlm.nih.gov/pubmed/31871513
http://dx.doi.org/10.1155/2019/2986286

Ejemplares similares